The Valens Company (TSX: VLNS) reported its third quarter financial results for the period ended August 31, 2020 this evening, reporting net revenues of $18.1 million along with a net loss of $3.1 million. Revenues increased 2.84% on a quarter over quarter basis, as well as 10.13% on a year over year basis.
Drilling down into the revenue figures, toll processing and co-packing saw revenues tick sharply down, falling from $7.3 million in the second quarter to $2.6 million in the third quarter. To counteract this fall, product sales, which includes white label arrangements, rose from $9.9 million to $15.0 million. Analytical testing meanwhile stayed flat at $0.4 million in revenues. The company guided within the associated press release that it expects product sales to continue to climb into the fourth quarter.
Cost of sales during the quarter amounted to $10.3 million, while writedowns of $0.5 million were also factored into the equation before the company posted its gross profit, which came in at $7.3 million.
While revenues were up on a quarter over quarter basis, so to were expenses which grew from $10.0 million in the second quarter to $10.7 million in the third quarter. Depreciation and amortization was the largest expense at $2.6 million, followed by wages and salaries and share based payments at $2.4 million and $1.6 million respectively. This, combined with other expenses of $0.2 million, lead to an after tax loss of $3.2 million for the company in the third quarter.
Looking to the balance sheet, Valens saw its cash position fall from $36.6 million to $30.3 million over the three month period. Trade and other receivables was relatively flat, falling from $35.0 million to $34.5 million, with current receivables representing roughly two full quarters worth of revenue. Inventory also fell from $28.2 million to $23.5 million. Total current assets fell overall during the quarter, from $119.5 million, to that of $105.8 million.
In terms of the outstanding receivables, $14.0 million is said to be over 60 days due. Addressing this issue, the company provides a very unclear statement, wherein it says, “Of the total invoiced trade receivables at August 31, 2020, the Company has subsequently collected, has trade payables outstanding with the same customers or has recorded a trade receivables valuation allowance loss provision representing 44% of the total balance.” 80% of the total $32.6 million in trade receivables outstanding is said to be from five licensed producers.
In terms of liabilities, accounts payables fell significantly, dropping to $13.8 million from $20.8 million. All other liabilities stayed relatively unchanged over the course of the quarter, with current liabilities dropping from $29.0 million to $22.3 million overall.
The Valens Company last traded at $1.72 on the TSX.
Information for this briefing was found via Sedar and The Valens Company. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.
As the founder of The Deep Dive, Jay is focused on all aspects of the firm. This includes operations, as well as acting as the primary writer for The Deep Dive’s stock analysis. In addition to The Deep Dive, Jay performs freelance writing for a number of firms and has been published on Stockhouse.com and CannaInvestor Magazine among others.